Oxytocin or Galantamine Versus Placebo for the Treatment of Negative Symptoms and Cognitive Impairments in Schizophrenia
Clinical trial NCT01012167 · COMPLETED
Trial details
- NCT number
- NCT01012167
- Sponsor
- University of Maryland, Baltimore
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2014-07-01
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.